The GastroPlus PHARMACEUTICAL Development Workshop
This record is part of
a dataset collected by the EU Commission in June-September 2018
. Some of these links will therefore die out with time.
Please see the
overview of courses maintained by ETPLAS
or contact Norecopa for more information.
Owner/Developer: SimulationsPlus
| Country: |
United States of America |
|---|---|
| Languages: |
English |
| Url: |
https://www.simulations-plus.com/assets/Electrolab_GastroPlus_Workshop_2018.pdf |
| Created: |
27 September 2018 |
| Locations: |
India |
| City: |
Mumbai |
| Description: | This two-day, hands-on course provides a working knowledge of the theories and application of our state-of-the-art PBPK modeling and simulation software to support internal research and regulatory interactions. A combination of presentations and interactive examples, taken from actual industry experience and using GastroPlus, illustrate how to recognize and deal with the multiple interacting phenomena that affect the absorption, pharmacokinetics, BABE and helpful for generic drug industry. |
| References: | https://www.simulations-plus.com/workshops/ |
| Format: |
Hands-on training, Lecture |
| Presence: |
Optional / Voluntary |
| Access: |
Fee-based |
| Content type: |
Theoretical, Practical |
| Duration: |
2 days |
| Frequency: |
Recurrent event |
| Prerequisites: |
This workshop is appropriate for sciensts in pharmaceutical development who need an in-depth understanding of how formulaon affects the highly interactive processes of dissolution, precipitation, gastrointesnal transit, absorption (passive and carrier-mediated), first-pass metabolism and pharmacokinetics. Although the course will use GastroPlus for all case studies, the guiding principles will be taught in a software-independent manner. Class size is limited to encourage interaction with the course instructors and among delegates. |
| Target audience: |
Professionals (e.g. veterinarians), Scientific officers / Project managers, Managers, Technicians, Teachers and educators, Regulators and policy-makers, Researchers, Students |
| Target sectors: |
SMEs, Consulting, Contract Research Organizations (CROs), Governmental bodies, Industry, Academia |
| Educational level: |
Postdoctoral (teaching and research), University (Doctoral education), University (Master), Continuing Professional Development |
| 3rs relevance: |
Replacement |
| Topics covered: |
Computational methods |
| 3rs coverage: |
Full coverage (a dedicated course) |
| Details on the topic or technology covered: |
Please also check the attached pdf file for training programme as well. Day 1: 1. Welcome and an overview of the GastroPlus™ PBPK modeling platform 2. Applicatons: QSAR/PBPK modeling integration– defining inputs through chemical structures and in silico F% simulations in animals and humans 3. Application: Mechanistic dissolutions modeling (aqueous solubility vs. pH, biorelevant solubility, preformulaon assessment, parcle size distributions) 4. Applications: Mechanistic dissolution & precipitation modeling (Z-factor options, precipitation kinetic features) 5. Applications: Mechanistic oral absorption modeling (the ACAT™ model, ASFs, paracellular absorption) Day 2 1.Applications: Systemic PK modeling considerations (PKPlus™ Module) 2. Applications: Mechanistic IVIVCs and virtual bioequivalence trials 3. Applications: Mechanistic IVIVCs and virtual bioequivalence trials (integration with DDDPlus™ for dissolution specifications) 4. Applications: Formulation optimization to hit target PK profiles 5. Applications: Additional dosage routes: Mechanistic dermal absorption models and IM models 6. Applications: Incorporating mechanistic modeling and simulation to assist with formulation development and regulatory evaluations |
| Learning outcome: |
What will you learn? Upon completion of this course you will have a thorough understanding of the interactions that exist among the various mechanistic phenomena affecting drug dissolution, absorption and pharmacokinetics and how they relate to the development of drug products both in preclinical and clinical settings. You will gain experience in: Assessing formulation strategies (e.g., micronization and nanoparticles) earlier in product development Analyzing the impact of common ion effect on solubility & dissolution Screening for different salts and understanding the effect on precipitation kinetics Properly using in vitro dissolution data to predict plasma concentration levels Deconvoluting in vivo dissolution to help design in vitro experiments and generate mechanistic IVIVCs Estimating local concentration of drug following dermal and intramuscular administration Running virtual bioequivalence studies to estimate sample sizes and achieve adequate power Understanding optimization methods, objective function weighing and constraints Designing controlled release products to reach therapeutic “windows” or target concentration profiles |
| Accreditation body and/or authority that approved the education or training: |
Electrolab Certified Course |
Did you find what you were looking for?
Yes, I found it! No, I did not!Thanks for your feedback! Please note that we cannot reply to you unless you send us an email.
What are you looking for?
We value your feedback so we can improve the information on the page. Please add your email address if you would like a reply. Thank you in advance for your help.!
Please contact us by email if you have any questions.